A Multi-centre, Double-blinded, Randomized, Placebo-controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir Plus Ribavirin in the Treatment of Severe Acute Respiratory Syndrome

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2013 by Hospital Authority, Hong Kong.
Recruitment status was  Not yet recruiting
Information provided by:
Hospital Authority, Hong Kong
ClinicalTrials.gov Identifier:
First received: December 20, 2007
Last updated: August 21, 2013
Last verified: August 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given